Sales rise 165.76% to Rs 4.89 crore
Net Loss of Norris Medicines reported to Rs 0.05 crore in the quarter ended June 2021 as against net loss of Rs 0.25 crore during the previous quarter ended June 2020. Sales rose 165.76% to Rs 4.89 crore in the quarter ended June 2021 as against Rs 1.84 crore during the previous quarter ended June 2020.
ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales4.891.84 166 OPM %10.431.09 -PBDT0.11-0.07 LP PBT-0.05-0.25 80 NP-0.05-0.25 80 Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
